| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.007 |